Journal article icon

Journal article

Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: comparison with histological subregions and impact on pharmacokinetic parameter analysis

Abstract:

Purpose

To use a novel segmentation methodology based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to define tumour subregions of liver metastases from colorectal cancer (CRC), to compare these with histology, and to use these to compare extracted pharmacokinetic (PK) parameters between tumour subregions.

Materials and Methods

This ethically-approved prospective study recruited patients with CRC and ≥1 hepatic metastases scheduled for hepatic resection. Patients underwent DCE-MRI pre-metastasectomy. Histological sections of resection specimens were spatially matched to DCE-MRI acquisitions and used to define histological subregions of viable and non-viable tumour. A semi-automated voxel-wise image segmentation algorithm based on the DCE-MRI contrast-uptake curves was used to define imaging subregions of viable and non-viable tumour. Overlap of histologically-defined and imaging subregions was compared using the Dice similarity coefficient (DSC). DCE-MRI PK parameters were compared for the whole tumour and histology-defined and imaging-derived subregions.

Results

Fourteen patients were included in the analysis. Direct histological comparison with imaging was possible in nine patients. Mean DSC for viable tumour subregions defined by imaging and histology was 0.738 (range 0.540-0.930). There were significant differences between K trans and k ep for viable and non-viable subregions (p < 0.001) and between whole lesions and viable subregions (p < 0.001).

Conclusion

We demonstrate good concordance of viable tumour segmentation based on pre-operative DCE-MRI with a post-operative histological gold-standard. This can be used to extract viable tumour-specific values from quantitative image analysis, and could improve treatment response assessment in clinical practice.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1016/j.ejrad.2020.108934

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
ORCID:
0000-0002-8432-2511


Cancer Research UK More from this funder
Grant:
18974


Publisher:
Elsevier
Journal:
European Journal of Radiology More from this journal
Volume:
126
Article number:
108934
Publication date:
2020-03-06
Acceptance date:
2020-03-01
DOI:
EISSN:
1872-7727
ISSN:
0720-048X
Pmid:
32217426


Language:
English
Keywords:
Pubs id:
1097197
Local pid:
pubs:1097197
Deposit date:
2020-06-17
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP